toxicity Cancer Research Results
toxicity, toxicity: Click to Expand ⟱
Colon, Colon Cancer: Click to Expand ⟱
Colon cancer can start anywhere in the colon, (5 feet long) and absorbs water from stool. Rectal cancer starts in the rectum, which is the last 12 centimeters.
|
Scientific Papers found: Click to Expand⟱
*BioAv↓, *Half-Life∅, selectivity↑, *toxicity↓, Wnt/(β-catenin)↓, P53↑, P21↑, PI3K↓, Akt↓, mTOR↓, TumCCA↑, TumCI↓, TumCMig↓, STAT3↓, PKM2↓, EMT↓, cl‑PARP↑, Casp3↑, Bax:Bcl2↑, VEGF↓, Hif1a↓, Dose∅, GLUT1↓, GlucoseCon↓,
| - |
in-vitro, |
Colon, |
HT-29 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
tumCV↓, *toxicity↓, ROS↑, mitResp↓, ChemoSen↑,
| - |
in-vitro, |
Colon, |
NA |
|
|
|
- |
in-vitro, |
Nor, |
YAMC |
|
|
|
TumCD↑, *toxicity↓, selectivity↑, ROS↑, *ROS∅, MMP↓, *MMP∅, PARP↑, BioAv↝,
| - |
vitro+vivo, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Colon, |
HCT116 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
Apoptosis↑, CSCs↓, TumVol↓, *toxicity↓, HSP70/HSPA5↓, OCT4↓, Nanog↓, cl‑PARP↑, cl‑Casp3↑,
AntiCan↑, Imm↑, antiOx↑, TumCP↓, Diff↑, TumCG↓, eff↑, P21↓, p27/CDKN1B↓, pRB↓, TumCCA↑, PI3K↓, Akt↓, PKCδ↓, RAS↓, ERK↓, NF-kB↓, Inflam↓, MMP9↓, IronCh↑, NK cell↑, selectivity↑, ChemoSen↑, chemoP↑, toxicity↓, Remission↑,
Apoptosis↑, ROS↑, lipid-P↑, selectivity↑, TumCP↓, *toxicity↓,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, lipid-P↑, 1, ROS↑, 3,
Metal & Cofactor Biology(tgid=2) ⓘ
IronCh↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
mitResp↓, 1, MMP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
GlucoseCon↓, 1, PKM2↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 2, Apoptosis↑, 2, Bax:Bcl2↑, 1, Casp3↑, 1, cl‑Casp3↑, 1, p27/CDKN1B↓, 1, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
pRB↓, 1, tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP70/HSPA5↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1, PARP↑, 1, cl‑PARP↑, 2,
Cell Cycle & Senescence(tgid=11) ⓘ
P21↓, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, Diff↑, 1, EMT↓, 1, ERK↓, 1, mTOR↓, 1, Nanog↓, 1, OCT4↓, 1, PI3K↓, 2, RAS↓, 1, STAT3↓, 1, TumCG↓, 1, Wnt/(β-catenin)↓, 1,
Migration(tgid=13) ⓘ
MMP9↓, 1, PKCδ↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↓, 1, VEGF↓, 1,
Barriers & Transport(tgid=15) ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Imm↑, 1, Inflam↓, 1, NF-kB↓, 1, NK cell↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, ChemoSen↑, 2, Dose∅, 1, eff↑, 1, selectivity↑, 4,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, chemoP↑, 1, Remission↑, 1, toxicity↓, 1, TumVol↓, 1,
Total Targets: 58
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS∅, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP∅, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, Half-Life∅, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 5,
Total Targets: 5
Scientific Paper Hit Count for: toxicity, toxicity
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:31 Cells:% prod#:% Target#:1025 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page